Rockland Immunochemicals

Philadelphia, United States Founded: 1962 • Age: 64 yrs
Rockland Immunochemicals is engaged in providing antibodies and biotechnology services.
Request Access

About Rockland Immunochemicals

Rockland Immunochemicals is a company based in Philadelphia (United States) founded in 1962. It operates as a Professional Services, and Direct-to-Consumer (D2C). Rockland Immunochemicals has completed 1 acquisition, including antibodies-online. Rockland Immunochemicals offers products and services including Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization. Rockland Immunochemicals operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.

  • Headquarter Philadelphia, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Rockland Immunochemicals, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $714.07 K (USD), Grant

    Sep 01, 2014

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Rockland Immunochemicals

Rockland Immunochemicals offers a comprehensive portfolio of products and services, including Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Antibodies are provided for research and diagnostics purposes.

Custom antibodies are developed for specific research needs.

Characterization services are offered for proteins and antibodies.

People of Rockland Immunochemicals
Headcount 50-200
Employee Profiles 40
Employee Profiles
People
David Chimento
Vice President Research And Development
People
Marcela Pacheco
Sr. Project Manager
People
Amber Sawyer
Scientist II
People
Anthony Fendrick
Sales Account Manager

Unlock access to complete

Funding Insights of Rockland Immunochemicals

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $714,072
  • First Round

    (24 Aug 2009)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2014 Amount Grant - Rockland Immunochemicals Valuation

investors

HHS
Aug, 2009 Amount Grant - Rockland Immunochemicals Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Rockland Immunochemicals

Rockland Immunochemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Rockland Immunochemicals

Rockland Immunochemicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include antibodies-online. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Online store for selling antibody kits
2006
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Rockland Immunochemicals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Rockland Immunochemicals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Rockland Immunochemicals

Rockland Immunochemicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
R&D focused on manufacturing of drugs for multiple therapeutic areas
domain founded_year HQ Location
CDMO offering drug and biologics development services
domain founded_year HQ Location
Selective Wnt agonists are developed for human tissue regeneration.
domain founded_year HQ Location
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
domain founded_year HQ Location
Drug research, development, testing, and consulting services are provided.
domain founded_year HQ Location
Protein therapeutics are developed and manufactured by WuXi Biologics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Rockland Immunochemicals

Frequently Asked Questions about Rockland Immunochemicals

When was Rockland Immunochemicals founded?

Rockland Immunochemicals was founded in 1962 and raised its 1st funding round 47 years after it was founded.

Where is Rockland Immunochemicals located?

Rockland Immunochemicals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

What does Rockland Immunochemicals do?

Rockland Immunochemicals is involved in the development and supply of high-quality antibodies, reagents, and custom services for research and diagnostics. The company serves industries such as AgBio, Biopharma, Diagnostics, and Emerging Therapeutics. Solutions include primary and secondary antibodies, custom antibody production, protein characterization, and assay development. Expertise is applied to advance life sciences through innovative products and technical support, fostering scientific discovery and development across multiple sectors.

Who are the top competitors of Rockland Immunochemicals?

Rockland Immunochemicals's top competitors include Novartis, Surrozen and Catalent.

What products or services does Rockland Immunochemicals offer?

Rockland Immunochemicals offers Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization.

How many acquisitions has Rockland Immunochemicals made?

Rockland Immunochemicals has made 1 acquisition, including antibodies-online.

Who are Rockland Immunochemicals's investors?

Rockland Immunochemicals has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available